Sign inJoin waitlistJoin the waitlist

Maria Cabanillas

, Professor of · University of Texas M D Anderson Cancer Center

Credentials: · · ·

History

University of Texas M D Anderson Cancer Center
Present

Endocrinology, Diabetes, and Metabolism
Baylor College of Medicine
2007–2009
Internal Medicine
University of Texas Health Science Center at Houston
1998–2001
University of Puerto Rico School of Medicine
1994–1998

Research

Thyroid cancer
Review · The Lancet · 2016 · First of 3 authors · Corresponding · 1,191 citations
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer
Journal of Clinical Oncology · 2018 · 704 citations
Thyroid Cancer: A Review
Review · JAMA · 2024 · Last of 3 authors · 655 citations

Naifa Busaidy
87 papers
Mark Zafereo
76 papers
Ramona Dadu
69 papers · 1 as a fellow
Michelle Williams
56 papers · 22 as a fellow
Mimi Hu
48 papers
Steven Waguespack
48 papers
Jennifer Wang
43 papers
Steven Sherman
36 papers
Anastasios Maniakas
32 papers · 1 as a fellow
Stephen Lai
32 papers
Priyanka Iyer
30 papers · 7 as a fellow
Brandon Gunn
25 papers

Clinical trials

IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATC
Principal investigator · Terminated · Phase 2
M.D. Anderson Cancer Center
2022–2025
Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2021–2027
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2017–2027
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2012–2028